Announcements Trials
Browse Landscape

Phase

Phase EARLY_PHASE1 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Thoracic 1Genitourinary 1Gastrointestinal 1Dermatologic 1CNS 1Breast 1

Conditions

Melanoma 1Lung Neoplasms 1Glioma 1Colonic Neoplasms 1Carcinoma, Renal Cell 1Breast Neoplasms 1Brain Neoplasms 1

Interventions

trametinib 3dabrafenib 3binimetinib 2Trastuzumab 2Paclitaxel 2Nivolumab 2Magnetic Resonance Spectroscopy 2Doxorubicin 2Docetaxel 2ulixertinib 1trastuzumab biosimilar HLX02 1sapanisertib 1romidepsin 1ripretinib 1relatlimab 1pertuzumab 1palbociclib 1osimertinib 1omipalisib 1liposomal doxorubicin 1larotrectinib 1ipatasertib 1glutathione pegylated liposomal doxorubicin 1erdafitinib 1entinostat 1diazepinomicin 1defactinib 1copanlisib 1cobimetinib 1clevudine 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Glioma × clevudine × Thoracic × Clear all
NCT04752267 2024-05-24

18F-FMAU PET/CT and MRI for the Detection of Brain Tumors in Patients With Brain Cancer or Brain Metastases

University of Southern California

Phase EARLY_PHASE1 Completed
10 enrolled
BreastCNSDermatologicGastrointestinalGenitourinaryThoracic

Brain Neoplasms, Breast Neoplasms, Carcinoma, Renal Cell, Colonic Neoplasms, Glioma, Lung Neoplasms, Melanoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡